3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Carcinoma in Situ
1
Breast Neoplasms
1
Interventions
valrubicin
1
dodecyl maltoside
1
Standard of Care
1
Physical Examination
1
Mitomycin
1
Methods
1
Mastectomy, Subcutaneous
1
Erlotinib Hydrochloride
1
Educational Status
1
Early Intervention, Educational
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 3
×
Carcinoma in Situ
×
Mastectomy, Subcutaneous
×
Clear all
NCT02311959
2026-04-14
MAPAM-01
Institut Claudius Regaud
Phase 3
Completed
450 enrolled